A Study of Radiologically Evident Treatment Effects in Subjects with Glioblastoma Multiforme (GBM)
Study of Treatment Effects in Subjects with Glioblastoma Multiforme (GBM) - Glioma, Brain Tumor
Sponsor: AbbVie
Enrolling: Male and Female Patients
IRB Number: AAAR1373
Contact: Research Nurse Navigator: 212-342-5162 / cancerclinicaltrials@cumc.columbia.edu
Additional Study Information: New data from the study of ABT-414 and ABBV-221 in patients with recurrent glioblastoma multiforme (GBM) have shown several examples where it seems evidence of disease progression (cancer that continues to grow and spread) was seen in MRI images, but examination of surgically removed tissue under the microscope did not agree with the MRI.
This study is closed
Andrew Lassman, MD
Do You Qualify?
Have you been diagnosed with glioblastoma? Yes No
Have you been previously treated in an ABT-414 or ABBV-221 clinical trial? Yes No
You may be eligible for this study

Place Holder

For more information, please contact:
Research Nurse Navigator